Related Articles
Molecular targeted therapies for cancer: Sorafenib monotherapy and its combination with other therapies (Review)
Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo
In situ downregulation of VLA-4 integrin cell surface expression during lymphoma growth and liver metastasis
Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma
Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma